-
How
#AI/#NLG can help cut cost, save time & improve quality of Patient Safety Narratives: Join#LifeSciences Senior VP Nishchal Sehgal for a discussion on why these solutions are beneficial at the#AMWA2019 conference today in San Diego#RegulatoryWriting#CurrentlyOrionpic.twitter.com/cVXnvXuQLr
-
#Turacoz shares#Thoughtfortheday#TuracozHealthcare#MedicalWritingService#PublicationSupport#RegulatoryWriting#MedicoMarketing#Confidence Visit our website: http://turacoz.com Email: hello@turacoz.inpic.twitter.com/HIKtZczkkn
-
#VIpry We are glad to welcome our new speaker@g_dranishdesai, Director, IntelliMed Healthcare Solutions for our 3rd Annual Pharma Regulatory Summit 2020 https://bit.ly/2MpCg7p#RegulatoryAffairs#RegulatoryWriting#MedicalWriting#Publishing#Submissions#scientificwriting -
#VIpry RAJESH KHER, Director, Business Operations, Regulatory#MedicalWriting,@JanssenGlobal R&D join us as new speaker for our 3rd Annual Pharma Regulatory Summit 2020 https://bit.ly/2MpCg7p#RegulatoryAffairs#RegulatoryWriting#Publishing#Submissions#scientificwriting -
Time for the
@amwa_southwest winter get together in New Mexico! Have a bite, clink your glass
, & learn about careers in #medicalwriting#sciencecommunication#editing#grantwriting#regulatorywriting. RSVP: https://buff.ly/2PFykAr@AmMedWriterspic.twitter.com/0OfMxz7bdN
-
Periodic Safety Update Report (PSUR) is a stand alone global-standardised document that can be used worldwide for identification of new signals in pharmacovigilance. Read our post at: https://www.clinskill.com/periodic-safety-update-reports/ …
#PSUR#medicalwriting#regulatorywriting#pharmacovigilancepic.twitter.com/vZ0Hw4IHlr
-
#TuracozSkillDevelopmentProgram#discuses the#DifferentHorizons of#MedicalWriting which includes#RegulatoryWriting#SafetyWriting#ScientificWriting#MedicalJournalism#MedicalEducation#MedicalMarketing To learn more, click on the link: https://www.turacozskilldevelopment.org/blog/medical-writing-as-a-promising-career-everything-you-need-to-know-40.html …pic.twitter.com/GsbfXPrFXW
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.